Notice of Intent to Grant Partially Exclusive License, 92858 [2016-30501]
Download as PDF
<![CDATA[
92858
Federal Register / Vol. 81, No. 244 / Tuesday, December 20, 2016 / Notices
Agenda: The tentative agenda for the
meeting of the Working Group on
Presumptions includes: general
comments on use of disease and
exposure presumptions in
compensation programs; current use of
presumptions in EEOICP; expanding/
improving the use of presumptions in
EEOICP; any new business as proposed
by working group members.
OWCP will transcribe the Advisory
Board working group meeting. OWCP
will post the transcripts on the Advisory
Board Web page, https://www.dol.gov/
owcp/energy/regs/compliance/
AdvisoryBoard.htm, along with written
comments and other materials
submitted to the working group or
presented at the working group meeting.
mstockstill on DSK3G9T082PROD with NOTICES
Public Participation, Submissions, and
Access to the Public Record
Working group meeting: The working
group will meet via teleconference on
Tuesday, January 10, 2017, from 1:00
p.m. to 3:30 p.m. Eastern Time.
Advisory Board working group meetings
are open to the public. The
teleconference number and other details
for listening to the meeting will be
posted on the Advisory Board’s Web site
no later than 72 hours prior to the
meeting. This information will be
posted at https://www.dol.gov/owcp/
energy/regs/compliance/
AdvisoryBoard.htm.
Requests for special accommodations:
Please submit requests for special
accommodations to participate in the
working group meeting by email,
telephone, or hard copy to Ms. Carrie
Rhoads, OWCP, Room S–3524, U.S.
Department of Labor, 200 Constitution
Avenue NW., Washington, DC 20210;
telephone (202) 343–5580; email
EnergyAdvisoryBoard@dol.gov.
Submission of written comments for
the record: You may submit written
comments, identified by the working
group name and the meeting date of
January 10, 2017, by any of the
following methods:
• Electronically: Send to:
EnergyAdvisoryBoard@dol.gov (specify
in the email subject line, ‘‘Working
Group on Presumptions’’).
• Mail, express delivery, hand
delivery, messenger, or courier service:
Submit one copy to the following
address: U.S. Department of Labor,
Office of Workers’ Compensation
Programs, Advisory Board on Toxic
Substances and Worker Health, Room
S–3522, 200 Constitution Ave. NW.,
Washington, DC 20210. Due to securityrelated procedures, receipt of
submissions by regular mail may
experience significant delays.
VerDate Sep<11>2014
19:36 Dec 19, 2016
Jkt 241001
Comments must be received by
January 3, 2017. OWCP will make
available publically, without change,
any written comments, including any
personal information that you provide.
Therefore, OWCP cautions interested
parties against submitting personal
information such as Social Security
numbers and birthdates.
Electronic copies of this Federal
Register notice are available at https://
www.regulations.gov. This notice, as
well as news releases and other relevant
information, are also available on the
Advisory Board’s Web page at https://
www.dol.gov/owcp/energy/regs/
compliance/AdvisoryBoard.htm.
FOR FURTHER INFORMATION CONTACT: You
may contact Antonio Rios, Designated
Federal Officer, at rios.antonio@dol.gov,
or Carrie Rhoads, Alternate Designated
Federal Officer, at rhoads.carrie@
dol.gov, U.S. Department of Labor, 200
Constitution Avenue NW., Suite S–
3524, Washington, DC 20210, telephone
(202) 343–5580. This is not a toll-free
number.
Signed at Washington, DC, this 14th day of
December, 2016.
Leonard J. Howie III,
Director, Office of Workers’ Compensation
Programs.
[FR Doc. 2016–30516 Filed 12–19–16; 8:45 am]
BILLING CODE 4510–24–P
NATIONAL AERONAUTICS AND
SPACE ADMINISTRATION
[Notice (16–089)]
National Aeronautics and
Space Administration.
ACTION: Notice of Intent to Grant
Partially Exclusive License.
AGENCY:
This notice is issued in
accordance with 35 U.S.C. 209(e) and 37
CFR 404.7(a)(1)(i). NASA hereby gives
notice of its intent to grant a partially
exclusive, license in the United States to
practice the inventions described and
claimed in U.S. Patent No. 7,623,972
entitled ‘‘Detection of Presence of
Chemical Precursors’’; U.S. Patent No.
7,801,687 entitled ‘‘Chemical Sensors
Using Coated Or Doped Carbon
Nanotube Networks’’; U.S. Patent No.
7,968,054 entitled ‘‘Nanostructure
Sensing and Transmission of Gas Data’’;
U.S. Patent No. 8,000,903 entitled
‘‘Coated or Doped Carbon Nanotube
Network Sensors as Affected by
Environmental Parameters’’; ARC–
16292–1 entitled ‘‘Nanosensor/Cell
Phone Hybrid for Detecting Chemicals
SUMMARY:
Frm 00089
Fmt 4703
The prospective partially
exclusive license may be granted unless,
within fifteen (15) days from the date of
this published notice, NASA receives
written objections including evidence
and argument that establish that the
grant of the license would not be
consistent with the requirements of 35
U.S.C. 209 and 37 CFR 404.7.
Competing applications completed and
received by NASA within fifteen (15)
days of the date of this published notice
will also be treated as objections to the
grant of the contemplated partially
exclusive license.
Objections submitted in response to
this notice will not be made available to
the public for inspection and, to the
extent permitted by law, will not be
released under the Freedom of
Information Act, 5 U.S.C. 552.
DATES:
Objections relating to the
prospective license may be submitted to
Patent Counsel, Office of Chief Counsel,
NASA Ames Research Center, Mail Stop
202A–4, Moffett Field, CA 94035–1000.
(650) 604–5104; Fax (650) 604–2767.
ADDRESSES:
Notice of Intent to Grant Partially
Exclusive License
PO 00000
and Concentrations’’; ARC–16902–1,
entitled ‘‘Nanosensor for Medical
Diagnoses’’; ARC–17110–1 entitled
‘‘Detection of Gases and Vapors at Low
Concentrations’’ to ENDO Medical Inc.,
having its principal place of business at
2345 Yale Street, 1st Floor, Palo Alto,
CA 94306. The patent rights in this
invention have been assigned to the
United States of America as represented
by the Administrator of the National
Aeronautics and Space Administration.
The prospective partially exclusive
license will comply with the terms and
conditions of 35 U.S.C. 209 and 37 CFR
404.7.
Sfmt 9990
FOR FURTHER INFORMATION CONTACT:
Robert M. Padilla, Chief Patent Counsel,
Office of Chief Counsel, NASA Ames
Research Center, Mail Stop 202A–4,
Moffett Field, CA 94035–1000. (650)
604–5104; Fax (650) 604–2767.
Information about other NASA
inventions available for licensing can be
found online at https://
technology.nasa.gov/.
Mark P. Dvorscak,
Agency Counsel for Intellectual Property.
[FR Doc. 2016–30501 Filed 12–19–16; 8:45 am]
BILLING CODE 7510–13–P
E:\FR\FM\20DEN1.SGM
20DEN1
]]>Agencies
[Federal Register Volume 81, Number 244 (Tuesday, December 20, 2016)]
[Notices]
[Page 92858]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30501]
=======================================================================
-----------------------------------------------------------------------
NATIONAL AERONAUTICS AND SPACE ADMINISTRATION
[Notice (16-089)]
Notice of Intent to Grant Partially Exclusive License
AGENCY: National Aeronautics and Space Administration.
ACTION: Notice of Intent to Grant Partially Exclusive License.
-----------------------------------------------------------------------
SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(e) and
37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant
a partially exclusive, license in the United States to practice the
inventions described and claimed in U.S. Patent No. 7,623,972 entitled
``Detection of Presence of Chemical Precursors''; U.S. Patent No.
7,801,687 entitled ``Chemical Sensors Using Coated Or Doped Carbon
Nanotube Networks''; U.S. Patent No. 7,968,054 entitled ``Nanostructure
Sensing and Transmission of Gas Data''; U.S. Patent No. 8,000,903
entitled ``Coated or Doped Carbon Nanotube Network Sensors as Affected
by Environmental Parameters''; ARC-16292-1 entitled ``Nanosensor/Cell
Phone Hybrid for Detecting Chemicals and Concentrations''; ARC-16902-1,
entitled ``Nanosensor for Medical Diagnoses''; ARC-17110-1 entitled
``Detection of Gases and Vapors at Low Concentrations'' to ENDO Medical
Inc., having its principal place of business at 2345 Yale Street, 1st
Floor, Palo Alto, CA 94306. The patent rights in this invention have
been assigned to the United States of America as represented by the
Administrator of the National Aeronautics and Space Administration. The
prospective partially exclusive license will comply with the terms and
conditions of 35 U.S.C. 209 and 37 CFR 404.7.
DATES: The prospective partially exclusive license may be granted
unless, within fifteen (15) days from the date of this published
notice, NASA receives written objections including evidence and
argument that establish that the grant of the license would not be
consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.
Competing applications completed and received by NASA within fifteen
(15) days of the date of this published notice will also be treated as
objections to the grant of the contemplated partially exclusive
license.
Objections submitted in response to this notice will not be made
available to the public for inspection and, to the extent permitted by
law, will not be released under the Freedom of Information Act, 5
U.S.C. 552.
ADDRESSES: Objections relating to the prospective license may be
submitted to Patent Counsel, Office of Chief Counsel, NASA Ames
Research Center, Mail Stop 202A-4, Moffett Field, CA 94035-1000. (650)
604-5104; Fax (650) 604-2767.
FOR FURTHER INFORMATION CONTACT: Robert M. Padilla, Chief Patent
Counsel, Office of Chief Counsel, NASA Ames Research Center, Mail Stop
202A-4, Moffett Field, CA 94035-1000. (650) 604-5104; Fax (650) 604-
2767. Information about other NASA inventions available for licensing
can be found online at https://technology.nasa.gov/.
Mark P. Dvorscak,
Agency Counsel for Intellectual Property.
[FR Doc. 2016-30501 Filed 12-19-16; 8:45 am]
BILLING CODE 7510-13-P
